BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 14/08/2024

Final Rule Places Zuranolone in Schedule IV of Controlled Substances Act

The Drug Enforcement Administration has finalized a rule placing zuranolone, a medication used to treat depression, in Schedule IV of the Controlled Substances Act, maintaining its classification as a medication with a high potential for abuse and dependence.

Source: Federal Register — Justice DepartmentOpen original release →